www.pharmavillage.com
- US Toll free:
- Regular US:
- UK:
- Pharmacy Categories
-
- Alcoholism
- Alzheimer's And Parkinson's
- Analgesics
- Anti-inflammatories
- Antiallergic
- Antibiotics
- Anticonvulsants
- Antidepressants
- Antifungals
- Antiparasitic
- Antivirals
- Arthritis
- Asthma
- Birth Control
- Cancer
- Cardiovascular Diseases
- Cholesterol
- Diabetes
- Diuretics
- Erectile Dysfunction
- Eye Care
- Gastrointestinal Tract
- HIV
- Hypertension
- Men's Health
- Mental Disorders
- Migraine
- Muscle Relaxants
- Neurological Disorders
- Obesity
- Osteoporosis
- Respiratory Tract
- Skin Care
- Surgery
- Urinary Tract
- Women's Health
Antivirals
Choose Your language:
- Testimonials
-
I have recept my package of viagra and cialis thanks you - joe
Read more »
- Articles
- News
-
- What’s best at beating swine flu, soap or gel?
- Commuters obsessively scrub their hands with gel
- Swine flu drug treatment will replace containment strategy
- More than 150 people have been diagnosed with swine flu over the past 24 hours as the rate of infection accelerates, pushing the total number of UK cases above 1,000
- Is the flu jab a waste of time?
- On balance, probably not
- Global flu pandemic would probably kill 62m, study says
- Around 62 million people in the world are likely to die if there is a flu pandemic and more than 70,000 of those deaths will be in the UK, according to a statistical analysis published today
- Vaccine against lethal strain of avian flu ready for human testing
- A British drug company is seeking permission to conduct the first human trials of an experimental vaccine against the avian flu virus
-
- Experts Offer Guidance on Use of DAAs for Difficult-To-Treat Hep C Patients - Gastroenterology & Endoscopy News
- Gastroenterology & Endoscopy NewsExperts Offer Guidance on Use of DAAs for Difficult-To-Treat Hep C PatientsGastroenterology & Endoscopy Newsby Christina Frangou San Francisco—For several months, it has been one of the most pressing questions among clinicians who treat patients with hepatitis C: How well do the two FDA-approved direct-acting antivirals (DAAs) perform in the patients who
- Antivirals Market to 2017 - Increased Uptake of High Priced Combination Drugs ... - MarketWatch (press release)
- Antivirals Market to 2017 - Increased Uptake of High Priced Combination Drugs
- New Antivirals Show Poor Safety in HCV With Cirrhosis - Medscape
- New Antivirals Show Poor Safety in HCV With CirrhosisMedscapeMay 2, 2012 (Barcelona, Spain) — Two relatively new direct-acting antiviral drugs have poor safety profiles in patients with hepatitis C virus (HCV) and cirrhosis, including a high rate of serious adverse events leading to study discontinuation
- AIDS Fight Enters New Phase with Prevention Pill - Pharmaceutical Processing
- Boston
- Research and Markets: Antivirals Market to 2017 - Increased Uptake of High ... - SunHerald.com
- Research and Markets: Antivirals Market to 2017 - Increased Uptake of High